263 related articles for article (PubMed ID: 33935750)
1. Organic Cation Transporter 1 an Intestinal Uptake Transporter: Fact or Fiction?
Wenzel C; Drozdzik M; Oswald S
Front Pharmacol; 2021; 12():648388. PubMed ID: 33935750
[TBL] [Abstract][Full Text] [Related]
2. Organic cation transporter 1 (OCT1/mOct1) is localized in the apical membrane of Caco-2 cell monolayers and enterocytes.
Han TK; Everett RS; Proctor WR; Ng CM; Costales CL; Brouwer KL; Thakker DR
Mol Pharmacol; 2013 Aug; 84(2):182-9. PubMed ID: 23680637
[TBL] [Abstract][Full Text] [Related]
3. Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1).
Nies AT; Herrmann E; Brom M; Keppler D
Naunyn Schmiedebergs Arch Pharmacol; 2008 Feb; 376(6):449-61. PubMed ID: 18157518
[TBL] [Abstract][Full Text] [Related]
4. Protein Abundance of Clinically Relevant Drug Transporters in the Human Liver and Intestine: A Comparative Analysis in Paired Tissue Specimens.
Drozdzik M; Busch D; Lapczuk J; Müller J; Ostrowski M; Kurzawski M; Oswald S
Clin Pharmacol Ther; 2019 May; 105(5):1204-1212. PubMed ID: 30447067
[TBL] [Abstract][Full Text] [Related]
5. Using Ex Vivo Porcine Jejunum to Identify Membrane Transporter Substrates: A Screening Tool for Early-Stage Drug Development.
Arnold YE; Kalia YN
Biomedicines; 2020 Sep; 8(9):. PubMed ID: 32927779
[TBL] [Abstract][Full Text] [Related]
6. Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs.
Urakami Y; Okuda M; Masuda S; Saito H; Inui KI
J Pharmacol Exp Ther; 1998 Nov; 287(2):800-5. PubMed ID: 9808712
[TBL] [Abstract][Full Text] [Related]
7. Morphine is a substrate of the organic cation transporter OCT1 and polymorphisms in OCT1 gene affect morphine pharmacokinetics after codeine administration.
Tzvetkov MV; dos Santos Pereira JN; Meineke I; Saadatmand AR; Stingl JC; Brockmöller J
Biochem Pharmacol; 2013 Sep; 86(5):666-78. PubMed ID: 23835420
[TBL] [Abstract][Full Text] [Related]
8. The Nonmetabolized β-Blocker Nadolol Is a Substrate of OCT1, OCT2, MATE1, MATE2-K, and P-Glycoprotein, but Not of OATP1B1 and OATP1B3.
Misaka S; Knop J; Singer K; Hoier E; Keiser M; Müller F; Glaeser H; König J; Fromm MF
Mol Pharm; 2016 Feb; 13(2):512-9. PubMed ID: 26702643
[TBL] [Abstract][Full Text] [Related]
9. Identification of Transporters Involved in Beraprost Sodium Transport In Vitro.
Oshida K; Shimamura M; Seya K; Ando A; Miyamoto Y
Eur J Drug Metab Pharmacokinet; 2017 Feb; 42(1):117-128. PubMed ID: 26961540
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory Effects of Green Tea and (-)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein.
Knop J; Misaka S; Singer K; Hoier E; Müller F; Glaeser H; König J; Fromm MF
PLoS One; 2015; 10(10):e0139370. PubMed ID: 26426900
[TBL] [Abstract][Full Text] [Related]
11. Organic Anion Transporting Polypeptide (OATP) transporter expression, localization and function in the human intestine.
Oswald S
Pharmacol Ther; 2019 Mar; 195():39-53. PubMed ID: 30347208
[TBL] [Abstract][Full Text] [Related]
12. Expression, regulation and function of intestinal drug transporters: an update.
Müller J; Keiser M; Drozdzik M; Oswald S
Biol Chem; 2017 Feb; 398(2):175-192. PubMed ID: 27611766
[TBL] [Abstract][Full Text] [Related]
13. Affinity of Ketamine to Clinically Relevant Transporters.
Keiser M; Hasan M; Oswald S
Mol Pharm; 2018 Jan; 15(1):326-331. PubMed ID: 29191019
[TBL] [Abstract][Full Text] [Related]
14. Reduced hepatic uptake and intestinal excretion of organic cations in mice with a targeted disruption of the organic cation transporter 1 (Oct1 [Slc22a1]) gene.
Jonker JW; Wagenaar E; Mol CA; Buitelaar M; Koepsell H; Smit JW; Schinkel AH
Mol Cell Biol; 2001 Aug; 21(16):5471-7. PubMed ID: 11463829
[TBL] [Abstract][Full Text] [Related]
15. Lack of Interactions Between an Antisense Oligonucleotide with 2'-O-(2-Methoxyethyl) Modifications and Major Drug Transporters.
Yu RZ; Warren MS; Watanabe T; Nichols B; Jahic M; Huang J; Burkey J; Geary RS; Henry SP; Wang Y
Nucleic Acid Ther; 2016 Apr; 26(2):111-7. PubMed ID: 26959999
[TBL] [Abstract][Full Text] [Related]
16. Why Does the Intestine Lack Basolateral Efflux Transporters for Cationic Compounds? A Provocative Hypothesis.
Proctor WR; Ming X; Bourdet D; Han TK; Everett RS; Thakker DR
J Pharm Sci; 2016 Feb; 105(2):484-496. PubMed ID: 26869413
[TBL] [Abstract][Full Text] [Related]
17. Functional identification of organic cation transporter 1 as an atenolol transporter sensitive to flavonoids.
Mimura Y; Yasujima T; Ohta K; Inoue K; Yuasa H
Biochem Biophys Rep; 2015 Jul; 2():166-171. PubMed ID: 29124159
[TBL] [Abstract][Full Text] [Related]
18. Protein Kinase C-Independent Inhibition of Organic Cation Transporter 1 Activity by the Bisindolylmaleimide Ro 31-8220.
Mayati A; Bruyere A; Moreau A; Jouan E; Denizot C; Parmentier Y; Fardel O
PLoS One; 2015; 10(12):e0144667. PubMed ID: 26657401
[TBL] [Abstract][Full Text] [Related]
19. Involvement of organic cation transporter 1 and CYP3A4 in retrorsine-induced toxicity.
Tu M; Li L; Lei H; Ma Z; Chen Z; Sun S; Xu S; Zhou H; Zeng S; Jiang H
Toxicology; 2014 Aug; 322():34-42. PubMed ID: 24799337
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3).
Jonker JW; Schinkel AH
J Pharmacol Exp Ther; 2004 Jan; 308(1):2-9. PubMed ID: 14576340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
